Full-3D Computer-Assisted Workflow for the Diagnosis and Correction of Deformities? Dentofacial
1 other identifier
observational
50
1 country
1
Brief Summary
"Dentofacial deformity refers to deviations from the norm of facial proportions and tooth ratios of such magnitude as to represent a disability." \[1\] These conditions afflicted two aspects of the patient's health: the first related to the functions performed by the stomatognathic apparatus (mastication, swallowing, phonation, etc...), the second related to the morphology of the face, which--by virtue of the severe disharmony of its parts--did not fully realize its function as an organ of relationships, leading the patient to high levels of psychological distress. The nature of the dentofacial deformities was mainly related to skeletal discrepancies between the maxillae, such that the malocclusion could not be resolved by orthodontic treatment alone. The resolution of these conditions required a perfect synergy between orthodontic therapy (aimed at dental alignment of the individual arches) and surgical therapy (aimed at morphological harmonization of the face and obtaining the correct occlusion).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 11, 2020
CompletedFirst Submitted
Initial submission to the registry
November 28, 2024
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 11, 2026
February 4, 2025
October 1, 2024
6.7 years
November 28, 2024
January 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
primary outcome
The primary outcome are : analyze the surgical orthodontic set-up at time T0 (pre-treatment phase) in relation to the decompensation orthodontics actually performed and the surgery actually planned at time T1 (pre-operative phase).
18 months
Secondary Outcomes (1)
secondary outcome
18 months
Other Outcomes (1)
pre-specified outcomes
18 months
Study Arms (3)
T0 Initial 3D study
T0: the patient has not yet started orthodontic-surgical treatment and is carrying out the initial documentation collection;
T1 Preoperative 3D study
T1: the patient one month before surgery who collects the preoperative documentation;
T2 Final 3D study
T2: the patient has completed the orthodontic-surgical treatment and performs the collection of the final documentation. It is carried out within 12 months of the intervention.
Interventions
To analyze the orthodontic-surgical set-up carried out as part of the normal care pathway of patients operated since January 2015 and who completed treatment on May 30, 2020 in the Orthodontic First patient.
Eligibility Criteria
All patients operated since January 2015 and who completed the "T2" follow-up by May 30, 2020, at the Maxillofacial Surgery Department (AOU di Bologna), who followed the normal care pathway provided for cases of dentoskeletal dysmorphosis, which consisted of: T0: Initial 3D study (before the start of orthodontic treatment) T1: Preoperative 3D study (1 month after surgery) T2: Final 3D study (at the end of post-operative orthodontic treatment with the appliance removed)
You may qualify if:
- Patients with dentoskeletal dysmorphia.
- Patients undergoing orthognathic surgery.
- Patients between 18 and 60 years of age at the time of orthognathic surgery.
- Patients with dentoskeletal dysmorphia.
- Patients undergoing orthognathic surgery.
- Patients between 18 and 60 years of age at the time of orthognathic surgery.
- Obtaining informed consent.
You may not qualify if:
- Patients who have undergone other facial surgeries during the treatment period.
- Patients who have not followed the data collection phases foreseen in the 3D Study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS - Azienda Ospedaliero Universitaria di Bologna
Bologna, Emilia-Romagna, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudio Marchetti, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 28, 2024
First Posted
February 4, 2025
Study Start
January 11, 2020
Primary Completion (Estimated)
September 11, 2026
Study Completion (Estimated)
November 11, 2026
Last Updated
February 4, 2025
Record last verified: 2024-10